Lisinopril

• Description :

  Lisinopril (MK-521) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.

• Product Name Alternative :

  MK-521

• UNSPSC :

  12352005

• Hazard Statement :

  H315, H319, H335, H361

• Target :

  Angiotensin-converting Enzyme (ACE)

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease; Cancer

• Assay Protocol :

  https://www.medchemexpress.com/lisinopril.html

• Purity :

  99.96

• Solubility :

  H2O : 50 mg/mL (ultrasonic)

• Smiles :

  O=C(O)[C@H]1N(C([C@H](CCCCN)N[C@H](C(O)=O)CCC2=CC=CC=C2)=O)CCC1

• Molecular Formula :

  C21H31N3O5

• Molecular Weight :

  405.49

• Precautions :

  H315, H319, H335, H361

• References & Citations :

  [1]Andujar-Sanchez, M., V. Jara-Perez, and A. Camara-Artigas, Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. FEBS Lett, 2007. 581 (18) : p. 3449-54.|[2]Song, J.C. and C.M. White, Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet, 2002. 41 (3) : p. 207-24.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  Launched

• CAS Number :

  [76547-98-3]